Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • US Senate passes bill to end debt ceiling stand-off and avoid default
    • Earth past its safe limits for humans, scientists say
    • US Senate races towards final vote on debt ceiling bill
    • Russian concerns on Ukraine must ‘be taken into account’, says Brazil
    • ‘Stream’ and ‘Torch’: the Gazprom-backed militias fighting in Ukraine
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • ‘Everyone will get affected’: Tesla jolts EV charging industry
      • Goldman warns of new job cuts in ‘tougher environment’ on Wall Street
      • AI will create ‘more losers than winners’ even as Nvidia soars
      • BHP to pay $280mn after underpaying 30,000 staff for years
      • Culture wars test corporate America’s commitment to Pride month
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news updates from June 1: US retailers warn on consumer spending, SpaceX wins Pentagon contract
      • Live news: Boris Johnson to send WhatsApp messages directly to Covid-19 inquiry
      • Rocket Internet backs away from start-up investing in tech downturn
      • Saudi Arabia expands lithium processing to supply BMW
      • UK’s pension lifeboat fund slashes equity allocation
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Beware ‘death by GPT syndrome’
      • We should stop worshipping at the altar of convenience
      • Why Wall Street is trying to shake up the 2024 race
      • Apple’s mixed reality headset is a hedge against disruption
      • How the Thatcherites lost their Brexit dream and their party
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • ‘Everyone has the right to completely log off’: what bosses think about the right to disconnect
      • Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Porsche, Bentley, Armani: Why Miami can’t build enough branded high rises
      • The UK’s best bakeries: the readers’ picks
      • Bruce Springsteen battles mortality in three-hour Edinburgh show
      • The big thing about tiny restaurants
      • An island-hopping idyll in Sweden’s Bohuslän archipelago
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Genomics

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Thursday, 1 June, 2023
      ‘Primate AI algorithm’ predicts genetic health risks

      Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans

    • Wednesday, 10 May, 2023
      Expanded ‘pan-genome’ database aims to improve treatment of diseases

      Project discovers more variation in DNA than expected, offering insights into human diversity

    • Wednesday, 12 April, 2023
      Medical science
      Genetic profile of lung cancer can predict disease’s next move

      UK scientists carry out most comprehensive study so far of tumour evolution and its implications for treatment

    • Wednesday, 5 April, 2023
      Anjana Ahuja
      We should learn from rival attempts to write pandemic history

      Data-sharing was messy, as shown by duelling claims about who published the coronavirus genome sequence first 

    • Monday, 13 March, 2023
      Illumina Inc
      Carl Icahn takes aim at genome sequencer Illumina over Grail deal

      Company’s shares jump after activist investor launches proxy battle

    • Wednesday, 8 March, 2023
      Cost of gene treatments for once incurable diseases too high, scientists warn

      Therapies based on editing of human genomes predicted to have a price tag of $2mn per patient

    • Wednesday, 8 March, 2023
      UK politics & policy
      Chinese genomics company accused of hack attempts by UK minister

      Government later says no ‘evidence’ of attempted hacking of NHS genetic data centre by BGI

    • Tuesday, 7 March, 2023
      Anjana Ahuja
      We need rules before we let the genome-editing genie out of the bottle

      Changing human DNA brings hope for treating diseases but raises concerns such as equitable access

    • Monday, 6 March, 2023
      Chris Miller
      There’s a new US national security obsession — biotech

      The ability to apply massive computing power to DNA is causing concern over biological warfare

    • Tuesday, 31 January, 2023
      Anjana Ahuja
      Dead as a dodo? The unsettling bid to bring back extinct species

      We should focus on conserving endangered animals rather than resurrecting those already gone

    • Sunday, 29 January, 2023
      News in-depthIllumina Inc
      Has Illumina taken the wrong path in its Grail quest?

      DNA sequencing expert’s investors question acquisition of cancer testing group that has also angered EU regulators

    • Friday, 6 January, 2023
      Medical science
      UK signs deal with BioNTech for cutting-edge cancer trials

      Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

    • Friday, 30 December, 2022
      UK to embark on groundbreaking new genomics projects

      Programmes involving millions of volunteers will cement Britain’s place as leader in DNA research

    • Tuesday, 13 December, 2022
      100,000 newborn babies set to have their DNA fully decoded

      Genomics England programme aims to extend the number of treatable conditions detected to about 200

    • Thursday, 10 November, 2022
      The Big Read
      Mood shifts on gene-edited crops as droughts and wars bite

      The European Commission is considering easing regulation on the technology. But critics say it is an untested risk being pushed by Big Ag

    • Monday, 3 October, 2022
      Nobel prizes
      Swedish geneticist wins Nobel prize for decoding DNA of human ancestors

      Svante Pääbo’s sequencing of the Neanderthal’s genome boosts understanding of evolution

    • Tuesday, 16 August, 2022
      Scientists vow to bring Tasmanian tiger back from extinction

      US biotech behind project to recreate woolly mammoth turns its attention to thylacine

    • Sunday, 14 August, 2022
      Biotech
      Cambridge start-up aims to rewrite the code of life

      Constructive Bio plans to reprogramme microbes to make new materials from drugs to biodegradable plastics

    • Thursday, 28 July, 2022
      Medical science
      First genetic treatment for inherited heart disease receives £30mn funding

      Injectable cure for congenital cardiomyopathies could be available within a few years, says UK charity

    • Tuesday, 24 May, 2022
      Agritech
      Plant scientists welcome UK bill to deregulate crop engineering

      Campaigners warn against loosening of gene editing rules made possible by Brexit

    • Sunday, 13 March, 2022
      ExplainerCoronavirus
      How can genomic sequencing spot the next coronavirus variant?

      Discovery of new strain that combines elements of Delta and Omicron shows importance of surveillance

    • Monday, 7 March, 2022
      Coronavirus treatment
      Scientists identify genetic factors behind severe Covid

      Sixteen genes that predispose people to critical illness pinpointed in world’s largest study of its kind

    • Wednesday, 9 February, 2022
      ReviewNon-Fiction
      Control by Adam Rutherford — the past and present dangers of eugenics

      The broadcaster and geneticist takes a clear-sighted look at a troublesome ideology

    • Wednesday, 12 January, 2022
      Coronavirus
      BioNTech and AI start-up develop tool to predict high-risk coronavirus variants

      Hopes early warning system will give policymakers and vaccine producers more time to address health risks

    • Tuesday, 7 December, 2021
      Coronavirus
      Omicron variant offshoot could make global tracking more difficult

      PCR tests will detect infections but uneven access to genomic surveillance hampers efforts to trace spread

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In